Terminal differentiation is a key element in the maintenance of tissue homeostasis in the epidermis. We show here that methotrexate (MTX) induces differentiation of human epidermal keratinocytes in vitro. MTX inhibits proliferation of keratinocytes and also induces several markers of differentiation: a change in cell morphology, a marked increase in cell size, an increase in the proportion of cells that express involucrin, and an increase in the amount of cornifled envelope protein. These effects of MTX are dose-and exposure-timedependent and become irreversible after 24 hr, approximately one population doubling time. These effects of MTX cannot be attributed to cytotoxicity since keratinocytes not only remain viable but also actively synthesize proteins. MTX causes reproducible changes in the SDS/PAGE profiles of newly synthesized proteins and, in particular, increases the amount of involucrin synthesis. Thymidine completely prevents these effects of MTX, suggesting that they are caused by a depletion of thymine deoxyribonucleotides. The effect of MTX on keratinocytes may provide a model for studying the relationship between deoxyribonucleotide metabolism and differentiation in normal cells. In addition, the ability of MTX to induce differentiation in keratinocytes suggests a mechanism to explain its therapeutic action in psoriasis.
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The normal human epidermis is a continuously renewing epithelium in which proliferation of keratinocytes is perfectly matched by loss of keratinocytes through differentiation and ultimate desquamation (1) . Epidermal hyperplasia occurs when either the rate of individual cell proliferation or the growth fraction increases (2, 3) . It has been proposed that one way to control hyperplasia or neoplasia is to induce differentiation, thereby limiting or reducing the growth fraction (4) (5) (6) .
Differentiation of keratinocytes in the epidermis is marked by a temporally and spatially well-defined sequence of morphological and biochemical changes (1, 7) . Differentiation of keratinocytes in culture is marked by many of the changes that occur in vivo: an increase in cell size (8) ; acquisition of a cornified cell envelope (9) ; expression of structural proteins (7, (10) (11) (12) , envelope precursors such as involucrin (8) , and the transglutaminase (10) that cross-links the envelope proteins.
Methotrexate (MTX) is an antifolate that was designed to inhibit cell proliferation by blocking de novo synthesis of nucleotide precursors of nucleic acid synthesis (13) . Some cells can be "rescued" after a long exposure to cytostatic concentrations of MTX suggesting that in these systems the effects of MTX are largely reversible (14) . In other cells, MTX can cause irreversible physiologic changes such as DNA damage (15) and, in some cases, induction of differentiation (16) (17) (18) .
MTX is an important therapy for psoriasis, a benign hyperproliferative disease of epidermal keratinocytes. The accepted rationale for its use is that it causes a temporary reversible inhibition of DNA synthesis and cell proliferation (19) . But that explanation for its efficacy has never been entirely convincing, leading to suggestions that it acts indirectly, for example, on the immune system (19) .
We recently observed, while studying the antiproliferative effects of MTX (20) , that it also had a pronounced effect on keratinocyte morphology and size. Since similar morphologic changes often accompany keratinocyte differentiation in vitro, we tested the hypothesis that MTX could induce differentiation and bring about an irreversible arrest of keratinocyte growth.
METHODS
Cell Culture. Cultures of human neonatal foreskin keratinocytes were grown and maintained as described (20, 21) . Second-or third-passage keratinocytes were seeded at 0.5-1 x 103 cells per cm2 in complete MCDB 153 medium. Complete MCDB 153 medium contains 0.1 mM Ca2', bovine pituitary extract (50 ,ug/ml), epidermal growth factor (10 ng/ml), insulin (5 ,ug/ml), hydrocortisone (0.5 ,ug/ml), and additional amino acids; this medium is formulated with Immunocytochemical Analysis for Involucrin. Involucrinpositive cells in culture dishes were identified by modification of a previously described method (21) . Briefly, cells in culture dishes were washed with phosphate-buffered saline (PBS) and permeabilized with methanol containing 0.3% H202. Nonspecific protein binding was blocked with normal swine serum and then cells were exposed to rabbit anti-human involucrin antibody (Biomedical Technologies, Stoughton, MA) followed by swine anti-rabbit IgG (DAKO, Carpinteria, CA) with intermediate washes using PBS. Finally, cells were exposed to rabbit horseradish peroxidase-anti-horseradish peroxidase complex (DAKO). Peroxidase activity was detected with Abbreviation: MTX, methotrexate. *To whom reprint requests should be addressed. 3,3'-diaminobenzidine. Cells processed as above, but without exposure to the involucrin antibody, showed no staining.
Protein Synthesis, SDS/PAGE, and Fluorography. Cells were exposed to [3H]leucine (20 ,utCi/ml; 1 Ci = 37 GBq) for 6 hr, washed with PBS, and removed from the dish with trypsin, and radioactivity in a sample was measured. After centrifugation, the cell pellet was suspended in 10%o (wt/vol) SDS and radioactivity was measured by scintillation counting.
In separate experiments, radioactively labeled proteins were solubilized and boiled in 40 mM Tris HCl (pH 8.8) containing 4% SDS, 20 mM dithiothreitol, 5 mM EDTA, 15%o
(wt/vol) sucro~se, and 0.02% bromophenol blue. Proteins were separated by SDS/PAGE on a 4-15%o polyacrylamide gradient gel using a discontinuous buffer system (22) . Molecular mass markers and purified involucrin (BTI) were analyzed concurrently. Gels were stained with Coomassie brilliant blue R250, impregnated with fluor (Amplify, Amersham), dried, and exposed to Kodak X-Omat/AR film for 4 days at -700C before development. Analysis of Cornified Envelope Protein. Cross-linked comnifled envelope protein was determined by the method of Hough-Monroe and Milstone (23) . Briefly, cells were re- moved from the culture dish with trypsin and counted. After centrifugation, the cell pellet was resuspended in 1% SDS/ 0.2% 2-mercaptoethanol to give 1 x 105 whole cells per ml and the cell suspension was boiled for 5 min. 
ation by 75% and increased the median cell volume by 225% ( Fig. 1 A and B) . Lower concentrations of drug had lesser effects. In the presence of growth-inhibitory doses of MTX, keratinocytes appeared larger and flatter and had a smaller nuclear-to-cytoplasmic ratio than control cells; some cells were elongated or polyangular but most cells were round; all appeared to have intact nuclei (Fig. 2 A-D) .
Most of the experiments reported here were done in medium containing an artificially low concentration of Ca2 , which is known to encourage growth and discourage differentiation (24) . A high physiologic concentration of Ca2"
facilitates the differentiation of keratinocytes in vitro (24) . Cultures switched from medium containing 0.1 mM to 2 mM Ca2+ respond to MTX in ways that are qualitatively similar to the response of cells in low Ca2 . MTX (1 ,uM) inhibited growth by 82% (data not shown) and caused changes in cell morphology (Fig. 2 E and F) .
Effect of MTX on Expression of Involucrim. The effect of growth-inhibitory doses of MTX on cell morphology and size suggested that MTX had induced differentiation. Therefore, we measured the expression of involucrin, a widely used marker of differentiation in keratinocytes (8), by determining the proportion of cells that expressed involucrin. MTX increased the proportion of involucrin-positive cells in a dose-dependent manner that correlated with inhibition of growth and increase in cell size (Fig. 1C) .
Effect of MTX on Cornified Envelope Protein. One wellrecognized marker of terminal differentiation in keratinocytes is the cornified envelope (9). The amount ofcornified envelope protein was determined after culturing keratinocytes for 6 days in the presence or absence of 1 ,M MTX. MTX clearly increased the amount of cornified envelope protein in cultures containing either 0.1 mM or 2 mM Ca2+ (Fig. 3) . In addition, MTX caused a severalfold increase in the proportion ofcells that had cornified envelopes visualized by phase-contrast microscopy (data not shown).
Effects of MTX on Cell Viability and Protein Synthesis. [3H]leucine for 6 hr. Cells were counted and radioactivity incorporated into protein was determined by scintillation counting. cells, keratinocyte proteins extracted after a 6-hr pulse with [3H]leucine were separated by SDS/PAGE.. The pattern of newly synthesized proteins was distinctly different in MTXtreated cells compared to control cells (Fig. 4) . Of particular interest was the relative increase per cell in synthesis of a protein that comigrated with purified involucrin. In addition to quantitative changes in these several bands, MTX treatment appeared to induce synthesis of several proteins and suppress the synthesis of others.
Time (Fig. 5) . Effect of Thymidine on Action of MTX. Thymidine has been shown to prevent the growth-inhibitory activity of MTX in keratinocytes (20) . To monitor the effects of thymidine on both growth and differentiation, thymidine was added to <-> E keratinocytes at various times after initiating treatment with 1 juM MTX. In the absence of thymidine, MTX inhibited growth and induced differentiation. Since the experimental medium contained adenine and folic acid, the immediate effects of MTX can be ascribed to its action on thymine deoxyribonucleotides. When thymidine was added to cells at the same time as MTX, the effects of MTX on growth and differentiation were prevented; in every way, these cultures appeared comparable to MTX-free control cultures (Figs. 2  and 6 ). Addition of thymidine 6 hr after the addition of MTX also prevented the effects of MTX. By contrast, addition of thymidine 24 hr after the addition of MTX failed to prevent the effects of MTX; growth was inhibited and percent of involucrin-positive cells increased to the same extent as in cultures receiving MTX alone.
DISCUSSION
The results presented herein demonstrate that MTX not only inhibited the proliferation of keratinocytes in vitro but also induced their differentiation. While growth arrest may be a necessary consequence of keratinocyte differentiation (25) , growth arrest does not necessarily result in the onset of differentiation (26) (27) (28) . For example, ethionine addition or isoleucine starvation causes a reversible growth arrest in the G, phase of the cell cycle that does not lead to keratinocyte differentiation (26, 27) .
The conclusion that MTX induces terminal differentiation of keratinocytes is based on morphological and biochemical criteria. The first clue that MTX might be inducing differentiation was the observation of an increase in cell size and decrease in nuclear-to-cytoplasmic ratio. Although many inhibitors of DNA synthesis routinely cause an increase in cell volume that can be attributed solely to continuing protein synthesis (29) , the relationship between differentiation and keratinocyte volume is well-established (8) .
Nonspecific toxicity cannot explain the changes caused by MTX insofar as treated cells had grossly normal membrane function (assessed by appropriate dye exclusion and uptake) and synthesized pr tein 2.3 times faster than control cells. This latter number compares favorably with the 2.5-fold increase in protein synthesis found in differentiated keratinocytes that had been separated from proliferating keratinocytes by size (30) .
Study of more specific biochemical markers confirmed that MTX was indeed inducing differentiation. Acquisition of a cornified cell envelope and expression of involucrin are widely used markers of keratinocyte differentiation (8, 9) .
The cornified cell envelope, generally considered a late marker of differentiation, consists of covalently cross-linked cell-membrane-associated proteins (10) . Formation of the cornified envelope requires synthesis of specific precursors, such as involucrin, as well as synthesis and activation of the cross-linking enzyme (10) . MTX increased the proportion of cells that expressed involucrin and also increased the amount of newly synthesized involucrin and total envelope protein per cell. Thus these data strongly support the contention that MTX induces keratinocyte differentiation.
The biochemical actions of MTX are well-known, thus allowing us to postulate a mechanism by which MTX induces differentiation in keratinocytes. MTX initially blocks dihydrofolate reductase, thereby preventing de novo synthesis of purine and pyrimidine nucleotides (13) . Since our test medium contains adenine but lacks thymidine, the actions of MTX should be attributable entirely to an inhibition of de novo synthesis of thymine deoxyribonucleotides. Prevention of all the effects of MTX on keratinocytes by the addition of thymidine to the culture medium provides strong evidence that MTX is acting by depleting the dTTP pool. The observation that there is a 24-hr window during which induction of differentiation by MTX can be prevented by thymidine suggests that the effect may occur at a specific point in the cell cycle. MTX blocks DNA synthesis and arrests cell growth at the G1-S interphase (14) ; perhaps this is also the point in the cell cycle from which differentiation is initiated by MTX.
There is precedent for irreversible disruption of normal cell physiology by an imbalance in nucleotide pools (31) . Many agents that deplete dTTP pools can cause mutations due to DNA damage (31) and MTX is known to cause DNA strand breaks (15) . There is also precedent for the ability of MTX to induce differentiation. In two other test systems, BeWo cells, a choriocarcinoma cell line (17) , and HL-60, a promyelocytic leukemia cell line (16, 18) , MTX induced differentiation that was attributed to changes in the thymine deoxyribonucleotide pools. Although reduction of dTTP pools can be caused by drugs, such as MTX, depletion ofdTTP might conceivably be a physiologic signal for keratinocytes to withdraw from the cell cycle and initiate a program of differentiation. Intracellular thymine deoxyribonucleotide pools are tightly regulated (32) and we recently demonstrated a correlation between onset of differentiation in keratinocytes and loss of the capacity to synthesize dTTP from extracellular thymidine (21) .
The therapeutic action of methotrexate in psoriasis, and perhaps in certain neoplastic diseases, needs-reevaluation in light of the results presented here. Psoriasis is a benign hyperproliferative disease of the epidermis in which the cell cycle time is many times faster than normal and the growth fraction is nearly twice normal (33) . The hypothesis that MTX is acting irreversibly in psoriasis by inducing terminal differentiation is consistent with several clinical observations. (i) Weekly pulse therapy with MTX controls hyperplasia despite the fact that inhibition of DNA synthesis lasts only 16-24 hr (34) . (ii) The appearance of "MTX-damaged cells" in plaques of psoriasis (34, 35) had been attributed to cell death. (iii) Curiously, MTX resistance has not been reported in chronically treated psoriatic keratinocytes (19) . These observations may be explained if MTX caused an induction of differentiation that resulted in irreversible withdrawal of cells from the proliferative compartment.
The investigations reported here demonstrate that MTX can induce differentiation in a normal cell. By inference, an inadequate supply of intracellular dTTP is the biochemical change responsible for that result. Consequently, the regulation ofthymine deoxyribonucleotide pools-both in normal keratinocyte physiology and as a target for pharmacologically induced differentiation-merits further study.
